Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Myeloid disease: Edited by Martin S. Tallman

Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia: when to change? A perspective in 2009

Mauro, Michael J

Author Information
Current Opinion in Hematology: March 2009 - Volume 16 - Issue 2 - p 135-139
doi: 10.1097/MOH.0b013e3283257b2b
  • Buy

Abstract

© 2009 Lippincott Williams & Wilkins, Inc.